Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about KAEMPFEROL: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | KAEMPFEROL |
| Key Genes/Proteins | CASP1, GPX4, NRF2, NLRP3, SNCA, IL1B |
| Related Diseases | ISCHEMIA, FERROPTOSIS, PARKINSON |
| Related Pathways | SNCA-INDUCED NEURODEGENERATION |
Knowledge base pages for this entity
graph TD
KAEMPFEROL["KAEMPFEROL"]
KAEMPFEROL -->|"inhibits"| NLRP3["NLRP3"]
KAEMPFEROL -->|"inhibits"| NLRP3_Inflammasome["NLRP3 Inflammasome"]
KAEMPFEROL -.protects against.-> Myocardial_Ischemia_Injury["Myocardial Ischemia Injury"]
KAEMPFEROL -->|"upregulates"| Autophagy["Autophagy"]
KAEMPFEROL -.protects against.-> Neurodegeneration["Neurodegeneration"]
KAEMPFEROL -->|"inhibits"| Oxidative_Stress["Oxidative Stress"]
KAEMPFEROL -->|"activates"| Macroautophagy["Macroautophagy"]
HDAC3["HDAC3"] -->|"targets"| KAEMPFEROL| Target | Relation | Type | Str |
|---|---|---|---|
| NLRP3 | inhibits | protein | 0.95 |
| NLRP3 Inflammasome | inhibits | pathway | 0.95 |
| Myocardial Ischemia Injury | protects_against | disease | 0.95 |
| Myocardial Ischemia Injury | treats | disease | 0.95 |
| Myocardial Injury | associated_with | disease | 0.95 |
| Oxidative Stress | associated_with | process | 0.95 |
| Autophagy | promotes | process | 0.95 |
| Autophagy | upregulates | process | 0.93 |
| Macroautophagy | promotes | process | 0.92 |
| Neurodegeneration | protects_against | process | 0.92 |
| Oxidative Stress | inhibits | process | 0.92 |
| Macroautophagy | activates | process | 0.90 |
| NLRP3 | inhibits | protein | 0.90 |
| NRF2 | activates | protein | 0.90 |
| Parkinson Disease | protects_against | disease | 0.90 |
| Neuroinflammation | inhibits | process | 0.90 |
| Autophagy | activates | process | 0.90 |
| CASP1 | inhibits | protein | 0.90 |
| CASP1 | downregulates | protein | 0.88 |
| Cardiac Function | associated_with | phenotype | 0.88 |
| IL1B | downregulates | protein | 0.88 |
| GPX4 | upregulates | protein | 0.88 |
| Superoxide Dismutase Activity | upregulates | biomarker | 0.85 |
| Malondialdehyde Concentration | downregulates | biomarker | 0.85 |
| IL1B | downregulates | protein | 0.85 |
| HDAC3 | targets | gene | 0.85 |
| Type 2 Diabetes Mellitus | contributes_to | disease | 0.85 |
| Ferroptosis | protects_against | process | 0.85 |
| Parkinson'S Disease | treats | disease | 0.85 |
| SNCA-INDUCED NEURODEGENERATION | protects_against | biological_process | 0.85 |
| Myocardial Mitochondrial Structure | protects_against | phenotype | 0.80 |
| PPAR | activates | protein | 0.80 |
| Aging | protects_against | process | 0.75 |
| Nrf2 | activates | protein | 0.72 |
| PPARG/TNC signaling pathway | regulates | pathway | 0.70 |
| Idiopathic pulmonary fibrosis | treats | disease | 0.70 |
| AKT | modulates | protein | 0.70 |
| PI3K | inhibits | protein | 0.70 |
| TNF | modulates | protein | 0.65 |
| ISCHEMIA | treats | disease | 0.65 |
| FERROPTOSIS | treats | phenotype | 0.65 |
| FERROPTOSIS | activates | phenotype | 0.65 |
| NEURONS | treats | cell_type | 0.65 |
| NLRP3 | associated_with | gene | 0.45 |
| CASP1 | associated_with | gene | 0.45 |
| SNCA | associated_with | gene | 0.45 |
| IL1B | associated_with | gene | 0.45 |
| TH | associated_with | gene | 0.45 |
| PARKINSON | associated_with | disease | 0.45 |
| AUTOPHAGY | associated_with | phenotype | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| HDAC3 | targets | gene | 0.82 |
| NRF2 | inhibits | gene | 0.65 |
| FERROPTOSIS | implicated_in | phenotype | 0.55 |
| NLRP3 INFLAMMASOME | associated_with | pathway | 0.45 |
| NEURODEGENERATION | associated_with | phenotype | 0.45 |
| GLIAL FIBRILLARY ACIDIC PROTEIN | associated_with | biomarker | 0.45 |
| DOPAMINERGIC NEURONS | associated_with | cell_type | 0.45 |
| SUBSTANTIA NIGRA | associated_with | brain_region | 0.45 |
| FERROPTOSIS | associated_with | phenotype | 0.45 |
| LIPID PEROXIDATION | associated_with | phenotype | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity